China's fast-developing biopharmaceutical industry is encountering a scale-up and production bottleneck.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Poor enforcement could jeopardize China's drug innovation policy
Rights and permissions
About this article
Cite this article
Jia, H. Chinese biotech hamstrung by production issues. Nat Biotechnol 25, 147–148 (2007). https://doi.org/10.1038/nbt0207-147
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0207-147
- Springer Nature America, Inc.
This article is cited by
-
Innovation capacity and economic development: China and India
Economic Change and Restructuring (2011)
-
Chinese health biotech and the billion-patient market
Nature Biotechnology (2008)